Qing Bile Therapeutics' Incubator/Accelerator Round

Qing Bile Therapeutics raised a round of funding on June 01, 2017. Investors include JLabs.

Qing Bile Therapeutics develops and commercializes effective pharmaceuticals based on its unique proprietary Tetrahydroxylated Bile Acid (THBA) Platform to treat bile acid imbalance metabolic diseases…

Articles about Qing Bile Therapeutics' Incubator/Accelerator Round: